Stay updated on M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page.

Latest updates to the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study details page shows updated core content, including revised eligibility criteria and listed locations.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page shows a new revision label, changing from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check25 days agoChange DetectedThe participating locations list has been updated with additions and removals across multiple sites and countries.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded: Show glossary feature; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page shows a minor revision note: Revision: v3.3.4 replaces v3.3.3, with no substantive changes to study details, enrollment, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page.